middle.news

Arovella Therapeutics Halts Trading Ahead of Capital Raise Details

9:15am on Monday 2nd of June, 2025 AEST Biotechnology
Read Story

Arovella Therapeutics Halts Trading Ahead of Capital Raise Details

9:15am on Monday 2nd of June, 2025 AEST
Key Points
  • Voluntary suspension effective from 10 February 2025
  • Suspension requested to manage continuous disclosure obligations
  • Material update related to capital raising placement announced in January
  • Suspension to last until announcement release or 17 February 2025
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about ALA
OPEN ARTICLE